• Lansoprazole Dispersible Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, MUPS-Based Dispersible Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the delicate, moisture-sensitive micro-pellets.

    Active IngredientStrengthPrimary Clinical Function
    Lansoprazole (as Enteric-Coated Micro-Pellets) USP/Ph.Eur.15 mgMaintenance & Pediatric Standard: Base therapeutic unit for healing maintenance, pediatric GERD, and preventing NSAID-induced gastric ulcers.
    Lansoprazole (as Enteric-Coated Micro-Pellets) USP/Ph.Eur.30 mgAcute Healing Standard: High-efficacy adult dosing for the rapid healing of erosive esophagitis, active duodenal ulcers, and H. pylori eradication protocols.
    ExcipientsMethacrylic Acid Copolymer (Enteric Coat) / Crospovidone / Microcrystalline Cellulose / Mannitol / Sucralose / Strawberry FlavorAcid-Resistant Shield / Superdisintegrant / Diluent / Sweetener (Engineered specifically to create a highly palatable, rapid-burst suspension that masks the bitter API, ensuring high pediatric compliance and smooth NG tube transit)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, highly monitored hospital and outpatient dispensing regimens).

  • Liv 52 tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Standardized Herbal Matrix Tablet, packed exclusively in highly secure, moisture-resistant PVC/PVDC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative botanical alkaloids.

    Standardized Botanical ExtractTarget BiomarkerPrimary Clinical Function
    Milk Thistle Ext. (Silybum marianum)Standardized to 70% Silymarin (140 mg)The Antioxidant Anchor: Massive glutathione restoration and hepatocyte membrane stabilization.
    Andrographis paniculata (Kalmegh) Ext.Standardized to 10% AndrographolidesThe Choleretic Catalyst: Potent antiviral properties (Hepatitis) and violent stimulation of bile flow to flush out hepatic toxins.
    Phyllanthus niruri (Bhumyamalaki) Ext.Standardized BittersThe Viral Blocker: Clinically documented to suppress the replication of the Hepatitis B virus and protect against drug-induced liver injury (DILI).
    Boerhavia diffusa (Punarnava) Ext.Standardized AlkaloidsThe Hepatic Diuretic: Reduces liver enlargement (hepatomegaly) and flushes out excess fluid accumulation (ascites) caused by liver failure.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Moisture-Barrier FilmDiluent / Superdisintegrant / Glidant / Film-Coating (Engineered specifically to lock out atmospheric moisture—which destroys botanical extracts—and completely mask the intensely bitter taste of Kalmegh and Silymarin)

    *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict 3-to-6 month chronic hepatology dispensing regimens).

  • Mesalazine Prolonged release Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, pH-Targeted PR Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative 5-ASA molecule.

    Active IngredientStrengthPrimary Clinical Function
    Mesalazine (5-ASA) USP/Ph.Eur.400 mg (PR)Initiation / Titration Standard: Base therapeutic unit for mild presentations or pediatric titration in pediatric gastroenterology.
    Mesalazine (5-ASA) USP/Ph.Eur.800 mg / 1200 mg (PR)Global Gastroenterology Standard: High-efficacy adult maintenance doses designed to improve patient compliance by drastically reducing the daily pill burden.
    ExcipientsMethacrylic Acid Copolymer Type B & C (Eudragit L/S) / Hypromellose / Triethyl Citrate / Iron Oxide Colors / TalcEnteric & Prolonged-Release Polymers / Plasticizer / Glidant (Engineered specifically to form an impenetrable, acid-resistant shield that strictly delays drug release until reaching the high-pH environment of the lower gastrointestinal tract)